published_or_final_version / Medical Sciences / Master / Master of Medical Sciences

published_or_final_version / Medicine / Master / Master of Philosophy

abstract / Biochemistry / Doctoral / Doctor of Philosophy

published_or_final_version / Public Health / Master / Master of Public Health

Optical molecular imaging has burgeoned into a major field within biomedicine, and technologies that incorporate surface plasmon resonance effects have become a major focus within this field. Plasmon resonance has been defined as the collective oscillation of the conduction band electrons in certain metals (such as gold) in response to an electric field, such as an impinging wave of light. We show that elastic light scattering due to the plasmon resonance of nanometer-sized gold particles makes them powerful tools for optical imaging of epidermal growth factor receptor (EGFR) expression -- a major biomarker for carcinogenesis. Optical technologies in general are poised as cheap, flexible ways to aid in diagnosis and treatment of disease. In addition to supplying a bright, stable optical scattering signal and a convenient conjugation platform for targeting molecules, these materials display a unique behavior termed "plasmon coupling". This term refers to the dramatic optical property changes brought about by the presence of other nearby nanoparticles. These changes include a dramatic red-shifting in their peak plasmon resonance wavelength, as well as a non-linear, per-particle increase in the overall scattered power. We show that such conditions exist in cells and are primarily due to intricate protein trafficking mechanisms as part of the EGFR life-cycle. The observed variations in plasmon coupling can give clues as to the nanoscale organization of these important proteins. In addition, the resulting optical property changes result in a large, molecular-specific contrast enhancement due to the shifting of the resonance closer to the near infrared region, where biological tissues tend to be most transparent. Despite this enhancement, however, many tissues contain large endogenous signals, as well as barriers to delivery of both light and the nanoparticles. As such, we also show an example of a multifaceted approach for further increasing the apparent molecular-specific optical signals in imaging of EGFR expression by using an oscillating magnetic field. This serves to encode the signal from magnetically susceptible plasmonic nanoparticles, making their extraction from the background possible. Overall, the studies presented in this dissertation should serve to stimulate further investigations into a wide variety of technologies, techniques, and applications.

Cell-cell signalling molecules play important roles in neural development. In response to extracellular signals, neuronal progenitor cells proliferate, differentiate, and form a neuronal network. In the vertebrate retina, retinal ganglion cells (RGCs) are the first neurons produced during development and are the only neurons that send projections to the brain. However, the molecular mechanisms for RGC development have not been fully understood. In this study, I have investigated the expression and functions of Nel (Neural Epidermal Growth Factor Like), an extracellular glycoprotein that contains chordin-like domains and epidermal growth factor-like domains, in the development of the chick RGCs and retinotectal projection. I found that on embryonic days (E) 2-3.5, Nel was expressed in the presumptive retinal pigment epithelium of the developing eye. Correspondingly, Nel-binding activity (Nel receptor activity) was detected in the retinal pigment epithelium and also the progenitor layer of the neural retina. At the early stages during RGC formation, Nel overexpression increased the total number of RGCs and accelerated the progression of RGC differentiation wave. Conversely, Nel expression knockdown decreased the total number of RGCs and slowed down the progression of RGC differentiation wave. At later stages (E3-E18), expression of Nel in the retina was in the retinal pigment epithelium and the RGC layer, whereas receptor activity for Nel was localized in the retinal pigment epithelium and the RGC axons. In vivo, Nel overexpression in the developing retina induced the inhibition of RGC axons and thus disrupting the intraretinal RGC axon projection. These results suggest that Nel can positively regulate the production of RGCs at the early stages during retinal development, and at the later stages, Nel can function as an inhibitory guidance cue in vivo for RGC axons.

No description available.

Tissue factor (TF) is a cell-associated receptor for coagulation factor VIIa (FVIIa) that initiates the coagulation cascade and transmits intracellular signals through protease activated receptors (PARs). This thesis documents for the first time that in human glioma cells (U373) oncogenic epidermal growth factor receptor (EGFRvIII) simultaneously upregulates the expression of several elements of the TF pathway (TF, FVIIa, PAR-1 and PAR-2). In the absence of EGFRvIII, TF triggers tumor formation, albeit with a long latency, while treatment of glioma cells with FVIIa activates MAPK phosphorylation and stimulates the expression of angiogenic factors (VEGF and IL-8). Moreover, selective targeting of the host (mouse) TF reveals its independent role in glioma tumorigenesis. We propose that TF may represent an attractive potential target to treat human brain tumors.

The problems and high medical costs associated with chronic wounds necessitate an economical bioactive wound dressing. A new strategy was investigated to inhibit MMP-9 proteases and to release epidermal growth factor (EGF) to enhance healing. Doxycycline (DOX) and EGF were encapsulated on polyacrylic acid modified polyurethane film (PAA-PU) using Layer-by-Layer (LbL) assembly. The number of bilayers tuned the concentration of DOX and EGF released over time with over 94% bioactivity of EGF retained over 4 days. A simple wound model in which MMP-9 proteases were added to cell culture containing fibroblast cells demonstrated that DOX inhibited the proteases providing a protective environment for the released EGF to stimulate cell migration and proliferation at a faster healing rate. In the presence of DOX, only small amounts of the highly bioactive EGF are sufficient to close the wound. Results show that this is new and promising bioactive dressing for effective wound management.

The problems and high medical costs associated with chronic wounds necessitate an economical bioactive wound dressing. A new strategy was investigated to inhibit MMP-9 proteases and to release epidermal growth factor (EGF) to enhance healing. Doxycycline (DOX) and EGF were encapsulated on polyacrylic acid modified polyurethane film (PAA-PU) using Layer-by-Layer (LbL) assembly. The number of bilayers tuned the concentration of DOX and EGF released over time with over 94% bioactivity of EGF retained over 4 days. A simple wound model in which MMP-9 proteases were added to cell culture containing fibroblast cells demonstrated that DOX inhibited the proteases providing a protective environment for the released EGF to stimulate cell migration and proliferation at a faster healing rate. In the presence of DOX, only small amounts of the highly bioactive EGF are sufficient to close the wound. Results show that this is new and promising bioactive dressing for effective wound management.